[1]
B. Kennedy, “Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis”, Sarcoidosis vasculitis and diffuse lung disease, vol. 32, no. 3, pp. 228-236, Sep. 2015.